Having focused on consolidating their industrial products businesses, Coventry Group (ASX: CYG) is seeing strong synergies realised from their efforts with its earnings for FY24 expected to be substantially up from the previous year, even with just a modest jump in revenue. Just a few days on from the end of FY24, Coventry Group’s preliminary
Read More
The XJO is expected to extend yesterday’s gains this morning despite a strong pullback in the U.S overnight. Their futures are in the green. CPI came in softer than expected, yet their market still sold down. This is perhaps due to a rotation out of the large companies that have seen the lion share of
Read More
A new drug seeking to treat irritability associated with Autism Spectrum Disorder (ASD) could soon be making its way to clinical trials in healthy volunteers after Zelira Therapeutics (ASX: ZLD) concluded a positive round of discussions with the United States Food and Drug Administration (FDA) on a study design. The proposed clinical trials are for
Read More
The XJO is expected to open higher this morning following a strong night of gains which saw the U.S once again finish in fresh all-time highs. Their futures are flat. We should open near 7,900, roughly our all-time high resistance. It would be hard to suggest that we will break through today, especially when we
Read More
Setting a foundation and shaping Queensland housing market, construction company Fleetwood (ASX: FWD) has won a contract to design, build, and install 60 homes for the Queensland Department of Housing, Local Government, Planning and Public Works. This aligns with Fleetwood’s strategy to expand its presence in the social housing sector and contribute to solving the
Read More
Can you make autistic people less autistic? Neurotech International (ASX: NTI) believes so based on data published from their Phase II/III clinical trial of NTI-164 which aims to treat Autism Spectrum Disorder (ASD). ASD is a complex neurodevelopmental condition that can manifest in various ways. From challenges in social interactions, repetitive behaviours, and restricted interests,
Read More